Skip to search formSkip to main contentSkip to account menu

Pegasys

National Institutes of Health

Related topics

Related topics

4 relations
1 ML peginterferon alfa-2a 0.18 MG/ML Injection [Pegasys]peginterferon alfa-2b

Broader (2)

peginterferon alfa-2apegylated interferon alfa

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Interferon to PEG-Interferon: A Review
The interferons (IFNs) are group of naturally occurring cytokines that are secreted by cells of mammalian immune system when they… 
2009
2009
Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report.
BACKGROUND Patients with concomitant hepatitis C (HCV) and B (HBV) infection are difficult to treat due to lack of medicines that… 
2007
2007
Baseline Serum Hepatitis C Virus (HCV) RNA Level and Response at Week 4 Are the Best Predictors of Relapse After Treatment With Pegylated Interferon Plus Ribavirin in HIV/HCV-Coinfected Patients
Background:Relapse after achieving virologic response to anti-hepatitis C virus (HCV) treatment considerably reduces sustained… 
2006
2006
8 24 Week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in HCV genotype 1 or 4 ‘super-responders’
2004
2004
95 Peginterferon alfa-2A (40KD) (PEGASYS®) monotherapy is more effective than lamivudine monotherapy in the treatment of HBEAG-negative chronic hepatitis B: 72-week results from a phase III…
2004
2004
[The pegasys using and HCV genotype were the independent predictors of the response to antiviral therapy in chronic hepatitis C].
OBJECTIVE To investigate the predictors of IFN therapy in patients with chronic hepatitis C through making the multivariate… 
2003
2003
Improved biological and transcriptional activity of monopegylated interferon-α-2a isomers
ABSTRACTThe addition of polyethyleneglycol (PEG) side chains to interferon α-2a improves the serum stability and clinical… 
2003
2003
Impact of group education on knowledge, satisfaction and quality of life among hepatitis C patients seen by gastroenterologists
2001
2001
Efficacy, safety, and tolerability in patients switched to PEG (40 kDa) IFN α-2a (PEGASYS®) after discontinuation from interferon alfa-2b plus ribavirin (REBETRON™) combination therapy for chronic…
1985
1985
PegaSys: A system for graphical explanation of program designs
This paper is an initial report on a system, called PegaSys, that supports a new visual paradigm for describing and manipulating… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)